These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2315971)

  • 1. Effect of ponsinomycin on single-dose kinetics and metabolism of carbamazepine.
    Couet W; Istin B; Ingrand I; Girault J; Fourtillan JB
    Ther Drug Monit; 1990 Mar; 12(2):144-9. PubMed ID: 2315971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of effect of ponsinomycin on the plasma pharmacokinetics of theophylline.
    Couet W; Ingrand I; Reigner B; Girault J; Bizouard J; Fourtillan JB
    Eur J Clin Pharmacol; 1989; 37(1):101-4. PubMed ID: 2591458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of ponsinomycin on the pharmacokinetics of dihydroergotamine administered orally.
    Couet W; Mathieu HP; Fourtillan JB
    Fundam Clin Pharmacol; 1991; 5(1):47-52. PubMed ID: 2066050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoinduction and steady-state pharmacokinetics of carbamazepine and its major metabolites.
    Kudriakova TB; Sirota LA; Rozova GI; Gorkov VA
    Br J Clin Pharmacol; 1992 Jun; 33(6):611-5. PubMed ID: 1389933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of ponsinomycin on the pharmacokinetics of nicoumalone enantiomers.
    Couet W; Istin B; Decourt JP; Ingrand I; Girault J; Fourtillan JB
    Br J Clin Pharmacol; 1990 Oct; 30(4):616-20. PubMed ID: 2291874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Steady-state pharmacokinetics of topiramate and carbamazepine in patients with epilepsy during monotherapy and concomitant therapy.
    Sachdeo RC; Sachdeo SK; Walker SA; Kramer LD; Nayak RK; Doose DR
    Epilepsia; 1996 Aug; 37(8):774-80. PubMed ID: 8764818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early stage autoinduction of carbamazepine metabolism in humans.
    Bernus I; Dickinson RG; Hooper WD; Eadie MJ
    Eur J Clin Pharmacol; 1994; 47(4):355-60. PubMed ID: 7875188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Influence of food intake on the bioavailability of ponsinomycin administered in a syrup form].
    Fourtillan JB; Couet W; Ingrand I; Reigner B; Bizouard J; Girault J
    Pathol Biol (Paris); 1989 May; 37(5):446-50. PubMed ID: 2789364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutual interaction between remacemide hydrochloride and carbamazepine: two drugs with active metabolites.
    Leach JP; Blacklaw J; Jamieson V; Jones T; Richens A; Brodie MJ
    Epilepsia; 1996 Nov; 37(11):1100-6. PubMed ID: 8917061
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of diosmin on the metabolism and disposition of carbamazepine in healthy subjects.
    Bedada SK; Boga PK
    Xenobiotica; 2017 Oct; 47(10):879-884. PubMed ID: 27690733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo determinations of carbamazepine and carbamazepine-10, 11-epoxide binding parameters to serum proteins in monotherapy patients.
    Kodama Y; Kuranari M; Kodama H; Fujii I; Takeyama M
    J Clin Pharmacol; 1993 Sep; 33(9):851-5. PubMed ID: 8227483
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Pharmacokinetics of ponsinomycin administered in a syrup form in single 400-800 and 1200 mg doses in healthy volunteers].
    Couet W; Girault J; Reigner B; Ingrand I; Bizouard J; Fourtillan JB
    Pathol Biol (Paris); 1989 May; 37(5):428-32. PubMed ID: 2789363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Kinetics of carbamazepine and carbamazepine-epoxide, determined by use of plasma and saliva.
    Westenberg HG; van der Kleijn E; Oei TT; de Zeeuw RA
    Clin Pharmacol Ther; 1978 Mar; 23(3):320-8. PubMed ID: 627139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbamazepine metabolism in man. Induction and pharmacogenetic aspects.
    Eichelbaum M; Tomson T; Tybring G; Bertilsson L
    Clin Pharmacokinet; 1985; 10(1):80-90. PubMed ID: 3971637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Free concentration of carbamazepine and carbamazepine-10,11-epoxide in children and adults. Influence of age and phenobarbitone co-medication.
    Riva R; Contin M; Albani F; Perucca E; Procaccianti G; Baruzzi A
    Clin Pharmacokinet; 1985; 10(6):524-31. PubMed ID: 4064451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation.
    Bertilsson L; Tomson T; Tybring G
    J Clin Pharmacol; 1986; 26(6):459-62. PubMed ID: 3734137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of lamotrigine on the pharmacokinetics of carbamazepine and its active metabolite in dogs.
    Matar KM; Nicholls PJ; Bawazir SA; Al-Khamis KI; Al-Hassan MI
    Eur J Drug Metab Pharmacokinet; 2001; 26(3):149-53. PubMed ID: 11695714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacokinetics of ponsinomycine with repeated ingestion in healthy volunteers].
    Couet W; Reigner BG; Ingrand I; Girault J; Istin B; Bizouard J; Fourtillan JB
    Therapie; 1990; 45(2):105-9. PubMed ID: 2353325
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of probenecid on the pharmacokinetics of carbamazepine in healthy subjects.
    Kim KA; Oh SO; Park PW; Park JY
    Eur J Clin Pharmacol; 2005 Jun; 61(4):275-80. PubMed ID: 15915352
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of phenobarbital on the pharmacokinetics of carbamazepine-10,11-epoxide, an active metabolite of carbamazepine.
    Spina E; Martines C; Fazio A; Trio R; Pisani F; Tomson T
    Ther Drug Monit; 1991 Mar; 13(2):109-12. PubMed ID: 2053116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.